In stock
Guaranteed refund or reship if you haven't received your order
Secure and encrypted payment processing
We ship to over 40 countries including the USA, UK, Europe, Australia and Japan

Eye drops "Olopatadine" are used to treat seasonal allergic conjunctivitis.


The active substance is olopatadine (1 ml of the drug contains 1 mg of olopatadine).

Excipients: sodium chloride, benzalkonium chloride, sodium hydrogen phosphate, sodium hydroxide or hydrochloric acid, water for injection.


Hypersensitivity to olopatadine or to any excipient of the drug.

Mode of application

For ophthalmic use only.

In the conjunctival sac of the affected eye (s), one drop of the drug should be instilled twice a day (with an interval of 8 hours). If necessary, treatment can last up to 4 months.

Use in elderly patients. There is no need for dose adjustment for this category of patients.

Use for children and adolescents. It can be used in pediatric practice for children aged 3 years and over in the same dosage as adults. The safety and effectiveness of the drug in children under 3 years of age has not been studied. Data for this age category are not available.

Use for impaired liver and kidney function. Studies of olopatadine in the form of eye drops in patients with impaired liver or kidney function were not performed. However, there is no need for dose adjustment in case of impaired liver or kidney function.

To prevent contamination of the dropper edge and contents of the vial, care must be taken not to touch the eyelids or other surfaces with the edge of the dropper cap. Close the vial tightly after each use.

If more than one ophthalmic agent is applied topically, the interval between their use should be at least 5 minutes. Eye ointments should be used last.

Application features

Pregnant women

Data on the ophthalmic use of olopatadine in pregnant women are not available or their number is limited. In animals, reproductive toxicity was found after systemic use. Olopatadine is not recommended for pregnant women and women of reproductive age who do not use contraceptives.

When administered orally to animals, olopatadine passes into breast milk. The risk to newborns / infants cannot be ruled out. The drug should not be used during lactation.

Studies to evaluate the effect of olopatadine on human reproductive function after topical ophthalmic administration have not been conducted.


The drug does not have or has a slight effect on the ability to drive vehicles and other mechanisms. As with any eye drops, temporary blurred vision or other visual impairment can affect the ability to drive vehicles or work with mechanisms. If blurred vision occurs during instillation, the patient must wait until vision is restored before driving or operating machinery.


There is no data on overdose in humans with accidental or intentional swallowing.

Side effects

A frequent side effect when using the drug is eye pain.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 ° C, out of the reach of children.

Shelf life - 2 years (after opening the bottle - no more than 4 weeks).

Tags: Olopatadine Hydrochloride